Correlation between conjunctival scraping cytology and other clinical dry eye metrics in determination of dry eye related inflammation

  • Bojana M Dačić Krnjaja University of Belgrade, Faculty of Medicine, Belgrade, SerbiaClinic for Eye Diseases, Clinical Center of Serbia, Belgrade, Serbia
  • Jelena Potić Clinic for Eye Diseases, Clinical Center of Serbia, Belgrade, Serbia
  • Danijela Raonić Clinical Centre of Montenegro, ‡Clinic for Eye Disease, Podgorica, Montenegro
  • Milenko Stojković University of Belgrade, Faculty of Medicine, Belgrade, SerbiaClinic for Eye Diseases, Clinical Center of Serbia, Belgrade, Serbia
Keywords: dry eye syndromes, conjunctiva, cytological techniques, sensitivity and specificity, diagnostic tests, routine, diagnosis, differential

Abstract


Abstract

 

Background/Aim. New and improved definition of dry eye disease (DED) emphasized that hiperosmolarity and in­flammation with initial tear film instability play etiological role. The aim of this study was to explore relation of some commonly used clinical tests to dry eye disease (DED) re­lated inflammation measured by conjunctival scraping cy­tology. Methods. We examined 100 subjects, 80 of them having DED. We performed Schirmer without anesthesia (Schirmer I), Fluorescein Tear Break Up Time (FTBUT), Rose Bengal (RB), Lid Parallel Conjunctival Folds (LIP­COF), Tear Meniscus Height (TMH) and Tear Ferning (TF) and compared the values to scraping scores of tarsal con­junctiva. Results. FTBUT had the best sensitivity (93.6%). The highest specificity was found with RB (93.2%), but it was also high with Schirmer I, TF and FTBUT (respectively 89.8%, 84.5%, 78.0%). RB and FTBUT had the highest cor­relation with conjunctival scraping score (r = 0.707, p < 0.001; r = -0.507, p < 0.001). Conclusion. In our study, FTBUT, though often used in many combinations of the DED tests, showed a remarkably high sensitivity and speci­ficity on its own, as well as good correlation with DED re­lated inflammation detected with conjunctival scraping cy­tology.

References

REFERENCES

The definition and classification of dry eye disease: Report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf 2007; 5(2): 75–92.

Baudouin C, Aragona P, Messmer EM, Tomlinson A, Calonge M, Boboridis KG, et al. Role of hyperosmolarity in the pathogenesis and management of dry eye disease: proceedings of the OCEAN group meeting. Ocul Surf 2013; 11(4): 246–58.

Aslan Bayhan S, Bayhan HA, Muhafız E, Bekdemir Ş, Gürdal CC. Effects of osmoprotective eye drops on tear osmolarity in contact lens wearers. Can J Ophthalmol 2015; 50(4): 283–9.

Leonardi A, Flamion B, Baudouin C. Keratitis in Dry Eye Disease and Topical Ciclosporin A. Ocul Immunol Inflamm 2017; 25(4): 577–86.

Craig JP, Nichols KK, Akpek EK, Caffery B, Dua HS, Joo CK, et al. TFOS DEWS II Definition and Classification Report. Ocul Surf 2017; 15(3): 276–83.

Versura P, Profazio V, Campos EC. Performance of tear osmo-larity compared to previous diagnostic tests for dry eye diseas-es. Curr Eye Res 2010; 35(7): 553–64.

Sambursky R, Davitt WF, Latkany R, Tauber S, Starr C, Friedberg M, et al. Sensitivity and specificity of a point-of-care matrix metalloproteinase 9 immunoassay for diagnosing inflammation related to dry eye. JAMA Ophthalmol 2013; 131(1): 24–8.

Messmer EM, von Lindenfels V, Garbe A, Kampik A. Matrix Metalloproteinase 9 Testing in Dry Eye Disease Using a Com-mercially Available Point-of-Care Immunoassay. Ophthalmol-ogy 2016; 123(11): 2300–8.

Versura P, Profazio V, Fresina M, Campos EC. A novel scraping cytology score system (SCSS) grades inflammation in dry eye patients. Curr Eye Res 2009; 34(5): 340–6.

Manthorpe R, Oxholm P, Prause JU, Schiødt M. The Copenhagen criteria for Sjögren's syndrome. Scand J Rheumatol Suppl 1986; 61: 19–21.

Höh H, Schirra F, Kienecker C, Ruprecht KW. Lid-parallel con-junctival folds are a sure diagnostic sign of dry eye. Der Oph-thalmologe 1995; 92(6): 802–8. (German)

Michel M, Sickenberger W, Pult H. The effectiveness of questionnaires in the determination of Contact Lens Induced Dry Eye. Ophthalmic Physiol Opt 2009; 29(5): 479–86.

Messmer EM. The pathophysiology, diagnosis, and treatment of dry eye disease. Dtsch Arztebl Int. 2015 Jan 30;112(5):71–81; quiz 82.

Methodologies to diagnose and monitor dry eye disease: report of the Diagnostic Methodology Subcommittee of the Interna-tional Dry Eye WorkShop (2007). Ocul Surf 2007; 5(2): 108–52.

Evans KS, North RV, Purslow C. Tear ferning in contact lens wearers. Ophthalmic Physiol Opt 2009; 29(2): 199–204.

Amparo F, Dastjerdi MH, Okanobo A, Ferrari G, Smaga L, Ha-mrah P, et al. Topical interleukin 1 receptor antagonist for treatment of dry eye disease: A randomized clinical trial. JAMA Ophthalmol 2013; 131(6): 715–23.

Stevenson W, Chauhan SK, Dana R. Dry eye disease: An immune-mediated ocular surface disorder. Arch Ophthalmol 2012; 130(1): 90–100.

Stern ME, Schaumburg CS, Pflugfelder SC. Dry eye as a mucosal autoimmune disease. Int Rev Immunol 2013; 32(1): 19–41.

Calonge M, Enríquez--Salamanca A, Diebold Y, González-García MJ, Reinoso R, Herreras JM, et al. Dry eye disease as an inflam-matory disorder. Ocul Immunol Inflamm 2010; 18(4): 244–53.

Alves M, Reinach PS, Paula JS, Vellasco CA, Bachette L, Faustino J, et al. Comparison of diagnostic tests in distinct well-defined conditions related to dry eye disease. PLoS ONE 2014; 9(5): e97921.

Bartlett JD, Keith MS, Sudharshan L, Snedecor SJ. Associations between signs and symptoms of dry eye disease: A systematic review. Clin Ophthalmol 2015; 9: 1719–30.

Lewis R. New New View of Dry Eye Stresses Mechanisms Over Manifestations. Medscape 2017. Available from:

http://www.medscape.com/viewarticle/879675?nlid=114929_450&src=WNL _mdplsfeat_170516_mscpedit_opth&uac= 159098SY&spon=36&impID=1348993&faf=1#vp_2 [cited 2017 May 8].

Vehof J, Sillevis Smitt-Kamminga N, Nibourg SA, Hammond CJ. Predictors of Discordance between Symptoms and Signs in Dry Eye Disease. Ophthalmology 2017; 124(3): 280–6.

Published
2021/04/21
Section
Original Paper